Sterling Investment Advisors Ltd. Raises Position in Astera Labs, Inc. $ALAB

Sterling Investment Advisors Ltd. increased its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 84.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,725 shares of the company’s stock after purchasing an additional 1,700 shares during the quarter. Sterling Investment Advisors Ltd.’s holdings in Astera Labs were worth $408,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the company. Reflection Asset Management bought a new position in Astera Labs during the fourth quarter valued at $25,000. Smartleaf Asset Management LLC increased its position in Astera Labs by 422.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the last quarter. Aventura Private Wealth LLC bought a new stake in shares of Astera Labs in the fourth quarter valued at $33,000. Hilltop National Bank raised its stake in shares of Astera Labs by 100.0% in the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after buying an additional 100 shares during the period. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new position in shares of Astera Labs during the 4th quarter valued at $33,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $361.78 on Wednesday. The business’s fifty day moving average is $342.03 and its 200 day moving average is $217.65. The firm has a market cap of $62.01 billion, a price-to-earnings ratio of 244.45, a PEG ratio of 4.07 and a beta of 3.66. Astera Labs, Inc. has a 52-week low of $88.73 and a 52-week high of $499.48.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s revenue was up 93.5% compared to the same quarter last year. During the same quarter last year, the company earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts predict that Astera Labs, Inc. will post 1.88 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In related news, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the transaction, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 3,505 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total transaction of $1,577,250.00. Following the sale, the director directly owned 57,466 shares in the company, valued at $25,859,700. This trade represents a 5.75% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 2,037,724 shares of company stock valued at $507,157,341. Company insiders own 10.40% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on ALAB. Royal Bank Of Canada increased their price target on Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 6th. JPMorgan Chase & Co. upped their price objective on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Evercore reiterated an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research report on Tuesday, May 19th. Barclays boosted their price target on shares of Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a research report on Thursday, May 7th. Finally, Jefferies Financial Group restated a “buy” rating and set a $270.00 price target on shares of Astera Labs in a research note on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and a consensus price target of $275.75.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.